Supplementary Table S3: Hazard ratios (HR) and confidence intervals (CI) for disease-free survival (DFS) using the two CTC variables and absolute CTC numbers before therapy from Prognostic Impact of Circulating Tumor Cells for Breast Cancer Patients Treated in the Neoadjuvant 'Geparquattro' Trial

Authors :: Klaus Pantel
Michael Untch
Gunter von Minckwitz
Christian Schem
Hans Tesch
Frank Holms
Jörn Hilfrich
Iris Schrader
Tanja Fehm
Jens Huober
Karsten Weber
Valentina Nekljudova
Sibylle Loibl
Volkmar Müller
Sabine Riethdorf
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Changes of CTC numbers in the total study cohort or in any of the different subgroups were not related to DFS.

Tools